Dc Investments Management, LLC Allakos Inc. Transaction History

Dc Investments Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 08, 2019	SELL	$31.59 - $62.65 $606,528 - $1.2 Million	-19,200 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$31.25 - $47.64 $600,000 - $914,688	19,200 New	19,200 $864,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $107M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dc Investments Management, LLC with notifications on news.